

Chief Development Officer, Early Phase
Job details:
The Chief Development Officer, Early Phase is responsible for designing and executing the strategy to grow a high-performing Phase 1 oncology clinical research program. Reporting to the President and Chief Medical Officer (CMO), this leader sets the scientific and operational direction for early-phase oncology trials, builds the portfolio and external partnerships, and ensures consistent delivery of safe, compliant, high-quality studies that attract sponsors, investigators, and patients. This is an opportunity to combine patient-centered oncology care with mission-driven research impact at scale across the Sarah Cannon Research Institute (SCRI) community-based oncology research network.
How to apply:
Reach out to scri.recruiting@scri.com for more information.


